Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Looking beyond the share price

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Oct 24, 2024 12:08pm

228 Views

Post# 36280415

RE:RE:RE:RE:RE:RE:Looking beyond the share price

I gotta say, it's a great time to buy....when mm's are manipulating like they are right now....when you can buy 40k shares and it only raises the share price 3 cents!......and the share price fell almost instantaneously back down 3 cents on a 100 share trade......shorty trying to accumulate much?

<< Previous

Bullboard Posts

Next >>

Mastering options Greeks: Essential knowledge for informed trading